SOHO Brazil 2023
Avatar

2023 SOHO® Brazil: "MDS & AML Classification Updates - Are Blast Counts Becoming Less Relevant?"

By SOHO Brazil 2023 FEATURING Valeria Santini
By SOHO Brazil 2023 FEATURING Valeria Santini
165 views
July 10, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Related Content

AUTOPLAY
22:37
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of Acute Leukemia and MDS - Highlig…

Feat. T. Badar
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
19:10
5th SOHO Italy Annual Conference

SOHO Italy 2023: How I Treat AML at MD Anderson Cancer Center

Feat. H. Kantarjian
16:55
Moffitt Cancer Center

Making Sense of the New Classification Systems for MDS in 2024

Feat. R. Komrokji
12:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Myeloid for Measure - New Therapeutics in…

Feat. A. Patel
27:28
UChicago Medicine

AML: Current Treatment Landscape and Key Recent Updates

Feat. A. Patel
44:26
University of Colorado Division of Hematology

Novel Therapies in AML and MDS

Feat. D. Pollyea
13:07
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Venetoclax With Azacitidine for Pts With Tr…

Feat. J. Garcia
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
32:04
Moffitt Cancer Center

Experts Discuss the Latest Data in Myeloid Diseases

Feat. A. Kuykendall, R. Komrokji, O. Chan, D. Sallman
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
16:59
MyCancerHaven

Experts Discuss Current and Future Management of AML

Feat. R. Vij, N. Daver
16:50
MDS Foundation

Pre-MDS States: How to Manage CHIP, CCUS and ICUS in the Clinic

Feat. M. Savona
29:20
MyCancerHaven

Experts Discuss Recent Advances in MDS

Feat. R. Vij, M. Sekeres
33:37
SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: MDS

Feat. G. Garcia-Manero
14:34
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "IMerge - Results From a Ph3 Study of Imet…

Feat. A. Zeidan
30:34
UChicago Medicine

2023 Updates in AML and MDS

Feat. O. Odenike
07:56
MDS Foundation

Debates in HR-MDS: Cytoreduction Should Precede Allo-HCT

Feat. U. Platzbecker